122 related articles for article (PubMed ID: 36228348)
21. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of KRAS Gene Expression and LCS6 Variant in Genomic and Cell-Free DNA of Iranian Women With Endometriosis.
Farahani MS; Shahbazi S; Moghaddam SA; Mahdian R
Reprod Sci; 2015 Jun; 22(6):679-84. PubMed ID: 25361550
[TBL] [Abstract][Full Text] [Related]
23. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
De Ruyck K; Duprez F; Ferdinande L; Mbah C; Rios-Velazquez E; Hoebers F; Praet M; Deron P; Bonte K; Speel EJ; Libbrecht L; De Neve W; Lambin P; Thierens H
Cancer Epidemiol; 2014 Oct; 38(5):591-8. PubMed ID: 25127693
[TBL] [Abstract][Full Text] [Related]
24. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
Chin LJ; Ratner E; Leng S; Zhai R; Nallur S; Babar I; Muller RU; Straka E; Su L; Burki EA; Crowell RE; Patel R; Kulkarni T; Homer R; Zelterman D; Kidd KK; Zhu Y; Christiani DC; Belinsky SA; Slack FJ; Weidhaas JB
Cancer Res; 2008 Oct; 68(20):8535-40. PubMed ID: 18922928
[TBL] [Abstract][Full Text] [Related]
25. Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Ganzinelli M; Rulli E; Caiola E; Garassino MC; Broggini M; Copreni E; Piva S; Longo F; Labianca R; Bareggi C; Fabbri MA; Martelli O; Fagnani D; Locatelli MC; Bertolini A; Valmadre G; Pavese I; Calcagno A; Sarobba MG; Marabese M
Sci Rep; 2015 Nov; 5():16331. PubMed ID: 26573509
[TBL] [Abstract][Full Text] [Related]
26. Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.
Crowley EH; Arena S; Lamba S; Di Nicolantonio F; Bardelli A
Hum Mutat; 2014 Feb; 35(2):208-14. PubMed ID: 24282149
[TBL] [Abstract][Full Text] [Related]
27. Association of Rs61764370 polymorphism within let-7 microRNA-binding site with lung cancer in Iranian population.
Farokhzad N; Hosseini SM; Edalat H; Sadeghi M
Afr Health Sci; 2020 Sep; 20(3):1299-1303. PubMed ID: 33402978
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
Hollestelle A; Pelletier C; Hooning M; Crepin E; Schutte M; Look M; Collee JM; Nieuwlaat A; Dorssers LC; Seynaeve C; Aulchenko YS; Martens JW; van den Ouweland AM; Weidhaas JB
Breast Cancer Res Treat; 2011 Jul; 128(1):79-84. PubMed ID: 20676756
[TBL] [Abstract][Full Text] [Related]
29. No evidence for genetic association with the let-7 microRNA-binding site or other common KRAS variants in risk of endometriosis.
Luong HT; Nyholt DR; Painter JN; Chapman B; Kennedy S; Treloar SA; Zondervan KT; Montgomery GW
Hum Reprod; 2012 Dec; 27(12):3616-21. PubMed ID: 23010532
[TBL] [Abstract][Full Text] [Related]
30. KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer.
Nelson HH; Christensen BC; Plaza SL; Wiencke JK; Marsit CJ; Kelsey KT
Lung Cancer; 2010 Jul; 69(1):51-3. PubMed ID: 19854534
[TBL] [Abstract][Full Text] [Related]
31. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
Hu H; Zhang L; Teng G; Wu Y; Chen Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
[TBL] [Abstract][Full Text] [Related]
32. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
[TBL] [Abstract][Full Text] [Related]
33. A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis.
Grechukhina O; Petracco R; Popkhadze S; Massasa E; Paranjape T; Chan E; Flores I; Weidhaas JB; Taylor HS
EMBO Mol Med; 2012 Mar; 4(3):206-17. PubMed ID: 22307873
[TBL] [Abstract][Full Text] [Related]
34. Associations of Polymorphisms Localized in the 3'UTR Regions of the
Insodaite R; Smalinskiene A; Liutkevicius V; Ulozas V; Poceviciute R; Bielevicius A; Kucinskas L
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828284
[TBL] [Abstract][Full Text] [Related]
35. The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Weidhaas JB; Harris J; Schaue D; Chen AM; Chin R; Axelrod R; El-Naggar AK; Singh AK; Galloway TJ; Raben D; Wang D; Matthiesen C; Avizonis VN; Manon RR; Yumen O; Nguyen-Tan PF; Trotti A; Skinner H; Zhang Q; Ferris RL; Sidransky D; Chung CH
JAMA Oncol; 2017 Apr; 3(4):483-491. PubMed ID: 28006059
[TBL] [Abstract][Full Text] [Related]
36. Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma.
Marinović S; Škrtić A; Catela Ivković T; Poljak M; Kapitanović S
Hum Cell; 2021 Sep; 34(5):1455-1465. PubMed ID: 34235620
[TBL] [Abstract][Full Text] [Related]
37. A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Chung CH; Lee JW; Slebos RJ; Howard JD; Perez J; Kang H; Fertig EJ; Considine M; Gilbert J; Murphy BA; Nallur S; Paranjape T; Jordan RC; Garcia J; Burtness B; Forastiere AA; Weidhaas JB
Ann Oncol; 2014 Nov; 25(11):2230-2236. PubMed ID: 25081901
[TBL] [Abstract][Full Text] [Related]
38. Lack of an Association between a Polymorphism in the KRAS 3' Untranslated Region (rs61764370) and Endometriosis in a Large European Case-Control Study.
D'Hooghe TM; Grechukhina O; Cho S; Fassbender A; O D; Peterse D; Weidhaas J; Taylor HS
Gynecol Obstet Invest; 2019; 84(6):575-582. PubMed ID: 31185482
[TBL] [Abstract][Full Text] [Related]
39. KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer.
Caiola E; Rulli E; Fruscio R; Buda A; Broggini M; Marabese M
Am J Cancer Res; 2012; 2(3):298-308. PubMed ID: 22679560
[TBL] [Abstract][Full Text] [Related]
40. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
